What class of medication does cefazolin belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefazolin Drug Classification

Cefazolin is a first-generation cephalosporin antibiotic, which belongs to the beta-lactam class of antimicrobial agents. 1, 2

Chemical Structure and Classification

  • Cefazolin is chemically defined as the sodium salt of 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]-methyl}-8-oxo-7-[2-(1H-tetrazol-1-yl) acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, confirming its cephalosporin structure 2

  • As a semi-synthetic cephalosporin, it is formulated for parenteral (intravenous) administration only 2

  • Each gram of cefazolin sodium contains 48 mg of sodium 2

Pharmacological Properties

  • Cefazolin demonstrates a narrow spectrum of antimicrobial activity compared to broader-spectrum beta-lactams, making it less likely to select for resistant organisms 1

  • It achieves high intraamniotic concentrations when administered intravenously, which is clinically relevant for obstetric prophylaxis 1

  • The drug exhibits low minimum inhibitory concentrations (<0.5 µg/ml) against Group B Streptococcus and other susceptible organisms 1

Clinical Context and Positioning

  • Cefazolin is classified as a first-generation cephalosporin, distinguishing it from second-generation agents (such as cefoxitin, cefuroxime, cefamandole) and third-generation agents (such as ceftriaxone, ceftazidime) 1, 3

  • It is the preferred agent for surgical prophylaxis across multiple surgical disciplines according to major international guidelines, including recommendations from the American Society of Health-Systems Pharmacists, IDSA, and WHO 3

  • The drug possesses a unique R1 side chain structure that differs from all penicillins and other cephalosporins, which has important implications for cross-reactivity patterns in allergic patients 4

Resistance Profile

  • Cefazolin demonstrates stability against many beta-lactamases, though it shows variable activity against organisms producing cephalosporinases 5

  • It maintains strong antibacterial activity against gram-positive bacteria, particularly Staphylococcus aureus, with more than 90% of strains suppressed at concentrations of 3.13 µg/ml or less 6

  • Among first-generation cephalosporins, cefazolin shows superior activity against gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.